RxDoctor Payments Data

Basker Periyasamy, MD

Nephrology · Henderson, NVNPI 1821187188

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.7% of the total across 162 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 24.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $861, 2.7 times the $321 reported in 2019.

$3,680in general payments, 2019–2025

Across 162 payments — averaging $22.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$882
  • AstraZeneca$466
  • Vifor Pharma, Inc.$383
  • Otsuka America Pharmaceutical, Inc.$333
  • Amgen$259
  • Merit Medical Systems Inc$159
  • plus $1K from 23 others

What the payments were for

  • Food & beverage$3,668100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,680 in reported general payments places this provider in the 70th percentile of 125 nephrology providers in Nevada.

See all nephrology providers in Nevada

Medicare billing

Part B allowed, 2024
$203,059
Medicare patients
391
Services billed
1,258

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
DapagliflozinDapagliflozin Propanediol12$5,453
Midodrine Hcl24$1,038
Gentamicin Sulfate25$919
Sevelamer Carbonate19$915
Megestrol Acetate19$842
Calcitriol21$511
Lidocaine-PrilocaineLidocaine/Prilocaine14$492
Losartan Potassium41$304
Lactulose17$241
Potassium Chloride16$177
Metoprolol Succinate20$143
Hydralazine Hcl15$122
Tamsulosin Hcl14$117
Amlodipine Besylate25$114
Terazosin Hcl14$106

Paid to pharmacies, not to this prescriber.

Other nephrology in Henderson

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →